EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.17, no.18, pp.2467-2473, 2013 (Journal Indexed in SCI)
Article / Article
Title of Journal :
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
BACKGROUND: Sustained suppression of serum HBV DNA levels with nucleos(t)ide analogues is the most important success obtained in the treatment of chronic HBV infection today. Tenofovir and entecavir provide more robust viral suppression.